Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oximix MV+
- Development stage
- Unknown
- Lead developer
- Driatec
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Oximix MV+ is a comprehensive multivitamin and multimineral dietary supplement developed by the Italian company Driatec. It is formulated to support the immune system and protect cells from oxidative stress, particularly in individuals facing physical or mental stress or maintaining active lifestyles. The supplement features a broad spectrum of micronutrients, including B-complex vitamins (B1, B2, B6, B12, niacin, pantothenic acid, folic acid), vitamins C, D, and E, and essential minerals such as magnesium, iron, zinc, copper, selenium, and manganese. Notably, the minerals are provided in highly bioavailable forms, specifically oxiprolinate (pidolate) and bisglycinate salts. Additionally, the formula incorporates potent antioxidants, including alpha-lipoic acid, coenzyme Q10, and reduced L-glutathione, to enhance its cellular protection profile.
- Brand names
- Oximix MV+
- Other names
- Oximix MV Plus
Beyond the preview
Go deeper on Oximix MV+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oximix MV+.